Why is Evoq Remedies falling/rising?

As of 11-Sep, Evoq Remedies Ltd is experiencing a decline in its stock price, currently at 3.68, which represents a decrease of 0.09 or 2.39%. The stock has been underperforming, having lost 8% over the last three days, and it is currently lower than the 5-day, 50-day, 100-day, and 200-day moving averages, although it is higher than the 20-day moving average. In terms of performance against benchmarks, the stock has shown a year-to-date decline of 52.82% and a one-year decline of 60.22%, indicating significant underperformance relative to the Sensex, which has gained 4.36% year-to-date.
In the broader market context, the stock's short-term performance over the past week shows a modest gain of 0.55%, but this is overshadowed by the Sensex's increase of 1.03% during the same period. The stock's liquidity is deemed sufficient for trading, as it is based on 2% of the 5-day average traded value. However, the absence of any positive or negative dashboard data limits the understanding of specific factors influencing the stock's recent movement. Overall, the combination of consecutive declines and significant underperformance against the benchmark suggests a challenging environment for Evoq Remedies Ltd.